The FDA warned diabetes patients of the risks of using homegrown treatment devices, such as unrecognized combos of CGMs and insulin pumps.

British biotech is often a disregarded backwater in life sciences, but today a host of good news has shone the spotlight back onto its potential.

The FBI has launched its own probe into some of the world’s largest medtech companies, stemming from a Brazilian corruption case, Reuters reports.

Yale researchers discovered that AstraZeneca’s anti-VEGF cancer drug cediranib may boost the effectiveness of PARP inhibitors.

The series B round comes shortly after Actuate dosed the first patient in a phase 1/2 trial of glycogen synthase kinase‐3 beta 9-ING-41.

AZ nets exec to lead breast cancer R&D; Teva stars in price-fix plot, but attorneys general say others "willingly" joined; EUSA Pharma nabs new…

Roche subsidiary Genentech put together an $800 million-plus deal to work with Parvus on drugs to treat autoimmune diseases.

J&J’s electrophysiology-focused Biosense Webster division launched a cloud-based network to link up the field’s myriad devices and share their data.